Bioalpha Holdings Bhd (0179) — Capital Reinvestment Ratio
Latest as of December 2024:
51.56x
Bioalpha Holdings Bhd (0179) has a Capital Reinvestment Ratio of 51.56x as of December 2024, meaning it reinvests 52% of its operating cash flow (RM44.47K) in capital expenditures (RM2.29 Million). See 0179 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
51.56x
Capex / Operating Cash Flow
Operating Cash Flow
RM44.47K
MYR
Capital Expenditures
RM2.29 Million
MYR
Data as of
Dec 2024
Most recent filing
Bioalpha Holdings Bhd Capital Reinvestment Ratio (2015–2024)
This chart tracks Bioalpha Holdings Bhd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Bioalpha Holdings Bhd (2015–2024)
Year-by-year Capital Reinvestment Ratio for Bioalpha Holdings Bhd from 2015 to 2024. For live market cap and broader valuation context, see Bioalpha Holdings Bhd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 25.78x | RM88.94K | RM2.29 Million | ▲ +1775.1% |
| 2023 | 1.37x | RM2.44 Million | RM3.36 Million | ▲ +82.1% |
| 2019 | 0.76x | RM16.27 Million | RM12.28 Million | ▼ -38.1% |
| 2018 | 1.22x | RM20.51 Million | RM25.02 Million | ▲ +77.2% |
| 2017 | 0.69x | RM40.37 Million | RM27.79 Million | ▼ -85.6% |
| 2016 | 4.77x | RM3.00 Million | RM14.29 Million | ▲ +69.7% |
| 2015 | 2.81x | RM5.28 Million | RM14.85 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow